Individuals must have completely recovered from the acute harmful results of all prior anti-most cancers therapy and must fulfill the next least duration from prior anti-cancer directed therapy prior to enrollment. A.G.H. has obtained study funding from Bayer AG and is a founder and shareholder of AMZL Therapeutics All of https://ariannao088frc2.mysticwiki.com/user